A new study has revealed that a cutting-edge blood test can diagnose Alzheimer’s disease with over 90% accuracy, offering a promising alternative to current diagnostic methods. Conducted by researchers at …
"treatment"
-
-
Hospitals and clinical laboratories across the United States are currently facing a severe shortage of blood culture bottles, specifically Becton Dickinson (BD) Bactec blood culture media bottles. This shortage poses …
-
A new study from UCLA has revealed that artificial intelligence (AI) is significantly more accurate than doctors in detecting prostate cancer. The study found that an AI tool, Unfold AI, …
-
America NowHealth
Lifestyle Changes Key to Preventing Half of Cancer Deaths, American Cancer Society Report Reveals
In a report by the American Cancer Society (ACS), researchers have identified that up to half of cancer deaths in the United States could potentially be prevented through lifestyle modifications. …
-
America NowHealth
Breakthrough in Gulf War Research: Scientists Identify Possible Cause of Veteran Illness
Recent research from Griffith University may have solved a longstanding mystery surrounding Gulf War Illness, a condition affecting up to one-third of veterans from the 1990-1991 Gulf War. This new …
-
America NowHealth
Rural America Faces Heart Health Crisis: Lack of Cardiologists in Nearly Half of U.S. Counties
Nearly half of the counties in the United States lack a practicing cardiologist, creating serious challenges for people needing specialized heart care. This shortage is especially severe in rural areas, …
-
Recent research has shown that Wegovy and Ozempic, two popular weight-loss drugs, may reduce the risk of several obesity-related cancers. The findings, published in the July 5 issue of JAMA …
-
President Joe Biden’s health has come under scrutiny following revelations that a renowned neurologist specializing in Parkinson’s disease has made multiple visits to the White House. According to visitor logs, …
-
The U.S. Food and Drug Administration (FDA) has approved a new drug, Kisunla (donanemab), aimed at treating Alzheimer’s disease. This approval is a significant development for patients in the early …
-
A major federal initiative aimed at reducing opioid overdose deaths by 40% has not met its goal, the National Institutes of Health (NIH) has announced. Launched in 2019, the HEALing …